Recent advances on small‐molecule nanomedicines for cancer treatment

Author(s):  
Xiangdong Xue ◽  
Aaron Lindstrom ◽  
Haijing Qu ◽  
Yuanpei Li
Author(s):  
Yuan Ma ◽  
Sifan Yu ◽  
Shuaijian Ni ◽  
Baoxian Zhang ◽  
Angela Chun Fai Kung ◽  
...  

Paclitaxel (PTX) has been used for cancer treatment for decades and has become one of the most successful chemotherapeutics in the clinic and financially. However, serious problems with its use still exist, owing to its poor solubility and non-selective toxicity. With respect to these issues, recent advances have addressed the water solubility and tumor specificity related to PTX application. Many measures have been proposed to remedy these limitations by enhancing tumor recognition via ligand-receptor-mediated targeting as well as other associated strategies. In this review, we investigated various kinds of ligands that have emerged as PTX tumor-targeting tools. In particular, this article highlights small molecule-, protein-, and aptamer-functionalized conjugates and nanoparticles (NPs), providing a promising approach for PTX-based individualized treatment prospects.


2015 ◽  
Vol 22 (5) ◽  
pp. 618-626 ◽  
Author(s):  
Peng-Cheng Lv ◽  
Juan Sun ◽  
Hai-Liang Zhu

Pharmaceutics ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 940
Author(s):  
Chaojie Zhu ◽  
Zhiheng Ji ◽  
Junkai Ma ◽  
Zhijie Ding ◽  
Jie Shen ◽  
...  

Cancer is one of the most devastating and ubiquitous human diseases. Conventional therapies like chemotherapy and radiotherapy are the most widely used cancer treatments. Despite the notable therapeutic improvements that these measures achieve, disappointing therapeutic outcome and cancer reoccurrence commonly following these therapies demonstrate the need for better alternatives. Among them, bacterial therapy has proven to be effective in its intrinsic cancer targeting ability and various therapeutic mechanisms that can be further bolstered by nanotechnology. In this review, we will discuss recent advances of nanotechnology-facilitated bacteria-based drug and gene delivery systems in cancer treatment. Therapeutic mechanisms of these hybrid nanoformulations are highlighted to provide an up-to-date understanding of this emerging field.


Author(s):  
Rong Xiang ◽  
Zhengsen Yu ◽  
Yang Wang ◽  
Lili Wang ◽  
Shanshan Huo ◽  
...  

2021 ◽  
Vol 50 (2) ◽  
pp. 702-734
Author(s):  
Luling Wu ◽  
Jihong Liu ◽  
Ping Li ◽  
Bo Tang ◽  
Tony D. James

In this tutorial review, we will explore recent advances for the design, construction and application of two-photon excited fluorescence (TPEF)-based small-molecule probes.


2021 ◽  
Author(s):  
Qiuran Wang ◽  
Sam H. Brooks ◽  
Tianchang Liu ◽  
Neil C. Tomson

This Feature Article describes recent advances in the design of multinucleating ligands that support small molecule activation chemistry.


2021 ◽  
Author(s):  
Hai-Hao Han ◽  
He Tian ◽  
Yi Zang ◽  
Adam C. Sedgwick ◽  
Jia Li ◽  
...  

This tutorial review describes recent advances involving small molecule fluorescent probes designed to aid in the study of major organ diseases.


Sign in / Sign up

Export Citation Format

Share Document